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ABSTRACT
Orexin and melanin-concentrating hormone (MCH) have been implicated in mediating a
variety of different behaviors. These include sleep and wakefulness, locomotion, ingestive behav-
iors, and fight-or-flight response, as well as anxiety- and panic-like behaviors in rodents. Despite
such diversity, all these processes require coordinated recruitment of the autonomic and somato-
motor efferents. We have previously mapped the locations of presympathetic-premotor neurons
(PSPMNs) in the rat brain. These putative dual-function neurons send trans-synaptic projections
to somatomotor and sympathetic targets and likely participate in somatomotor-sympathetic
integration. A significant portion of these neurons is found within the dorsomedial (DMH) and
lateral hypothalamus (LH), areas of the brain that contain MCH- and orexin- synthesizing
neurons in the central nervous system. Thus, we hypothesized that hypothalamic PSPMNs
utilize MCH or orexin as their neurotransmitter. To test this hypothesis, we identified PSPMNs
by using recombinant strains of the pseudorabies virus (PRV) for trans-synaptic tract tracing.
PRV-152, a strain that expresses enhanced green fluorescent protein, was injected into sympa-
thectomized gastrocnemius muscle, whereas PRV-BaBlu, which expresses -galactosidase, was
injected into the adrenal gland in the same animals. By using immunofluorescent methods, we
determined whether co-infected neurons express MCH or orexin. Our findings demonstrate that
PSPMNs synthesizing either MCH or orexin are present within LH, where they form two
separate populations. PSPMNs located around the fornix express orexin, whereas those located
around the cerebral peduncle are more likely to express MCH. These two clusters of PSPMNs
within LH likely play distinct functional roles in autonomic homeostasis and stress coping
mechanisms. J. Comp. Neurol. 505:586–601, 2007. © 2007 Wiley-Liss, Inc.
Indexing terms: somatomotor-sympathetic integration; somatomotor control; central autonomic
circuits; pseudorabies virus; peptides; transneuronal tracing
Orexins (orexin-A and orexin-B; also known as hypocre-
tin 1 and hypocretin 2, respectively) were initially discov-
ered as ligands for two orphan G-protein-coupled recep-
tors (de Lecea et al., 1998; Sakurai et al., 1998). These
peptides are derived from a common precursor molecule,
prepro-orexin, which is cleaved to form orexin-A (33 amino
acids long) and orexin-B (28 amino acids) (Sakurai et al.,
1998; Willie et al., 2001). In their initial report Sakurai et
al. (1998) described the structure of these peptides and
demonstrated that they stimulate short-term food intake.
Subsequent investigations have confirmed that these pep-
tides stimulate arousal and feeding behavior in rats and
mice (Edwards et al., 1999; Haynes et al., 2000, 2002) and
have also implicated them in the regulation of emotion,
energy homeostasis, reward, and drug addiction (Ya-
manaka et al., 2003; Akiyama et al., 2004; Boutrel et al.,
2005; Harris et al., 2005; Narita et al., 2006; Sakurai,
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2007). It has also been demonstrated that the orexins
participate in regulating locomotor activity as part of mo-
tivated behaviors, such as foraging for food following fast-
ing (Yamanaka et al., 2003) and that they are part of an
integrated cardiovascular and locomotor response to acute
stress (Zhang et al., 2006). In addition, intracerebroven-
tricular administration of orexin-A leads to increases in
mean arterial pressure and heart rate in awake behaving
rats (Samson et al., 2007).
Orexin-synthesizing neurons in the central nervous sys-
tem are found exclusively within the lateral (LH) and
dorsomedial (DMH) hypothalamic nuclei (Sakurai et al.,
1998; Swanson et al., 2005). Within these regions, orexin-
synthesizing neurons are intermingled with those neu-
rons that synthesize melanin-concentrating hormone
(MCH). Although these two populations of hypothalamic
neurons are located within the same areas, they are neu-
rochemically distinct, as MCH-positive cells do not syn-
thesize orexins and vice versa (Bayer et al., 2002; Swan-
son et al., 2005).
MCH is also located in the lateral hypothalamus and is
a 19-amino-acid-long neuroactive peptide that is derived
from the precursor prepro-MCH (Bittencourt et al., 1992).
MCH was originally discovered in fish but has subse-
quently been identified in mammals, in whom it is thought
to regulate energy balance (Pissios et al., 2006). In addi-
tion to energy balance, MCH neurotransmission has also
been implicated in regulating locomotor activity (Marsh et
al., 2002; Segal-Lieberman et al., 2003), and inactivation
of the MCH receptor 1 leads to increased wheel running
(Zhou et al., 2005). MCH neurotransmission is also
thought to play a role in mediating anxiety- and
depression-like behaviors in rodents (Borowsky et al.,
2002). Furthermore, intracerebroventricular infusions of
MCH increase rapid eye movement sleep (Verret et al.,
2003) and produce bradycardic and hypotensive responses
in rats (Messina and Overton, 2007), suggesting that
MCH neurotransmission also participates in regulation of
the autonomic nervous system and the sleep/wake cycle.
Taken together, these data suggest that orexins and
MCH participate in coordinating activities of somatomotor
and autonomic systems and that they do so within the
context of motivated behaviors. We have previously used a
virally mediated trans-synaptic tract-tracing approach to
map the locations of neurons that send polysynaptic pro-
jections to skeletal muscle and to the adrenal gland (Ker-
man et al., 2003, 2006a,b). We have proposed that these
neurons (referred to here as presympathetic-premotor neu-
rons [PSPMNs]) have dual functions in regulating activi-
ties of the sympathetic and somatomotor systems. Al-
though PSPMNs are widely distributed throughout the
brain, major clusters of these neurons are found within
areas thought to mediate motivated behaviors such as
responses to stress (Kerman et al., 2003, 2006a,b). Such
areas include LH and DMH, both regions that have been
implicated in mediating stress responses as well as regu-
lating food intake (Kerman et al., 2006a). These areas also
contain all the orexin-synthesizing neurons and the ma-
jority of MCH-synthesizing neurons in the central nervous
system (Bittencourt et al., 1992; Sakurai et al., 1998).
Thus, given the proposed role of PSPMNs in regulating
physiological aspects of motivated behaviors and the
known role of orexins and MCH in coordinating somato-
motor and autonomic functions, we hypothesized that a
subset of hypothalamic PSPMNs synthesize orexins or
MCH. To test this hypothesis we identified PSPMNs by
using our previously developed retrograde trans-synaptic
tract-tracing paradigm and then used triple-label immu-
nofluorescence to determine whether these cells synthe-
size orexins or MCH.
MATERIALS AND METHODS
All the procedures regarding animal use in this study
conformed to the Guide for the Care and Use of Laboratory
Animals of the NIH and were approved by the University
of Michigan’s University Committee on Use and Care of
Animals.
Antibody specificity and distribution of
MCH- and orexin-synthesizing neurons
In our initial experiments we sought to compare the
distribution of MCH- and orexin-synthesizing neurons in
the rat brain. Adult male Sprague-Dawley rats (n  2;
Charles River, Wilmington, MA) were used in these stud-
ies. Animals were deeply anesthetized with 1 ml i.p. of 50
mg/ml pentobarbital sodium solution and transcardially
perfused with 100–150 ml of physiological saline followed
by 400–500 ml of a 4% paraformaldehyde solution con-
taining 1.4% l-lysine and 0.2% sodium meta-periodate
(PLP) (McLean and Nakane, 1974). Brains were then ex-
tracted, postfixed in PLP overnight, and immersed in 20%
sucrose until they sank to the bottom of the container.
Tissue was then sectioned coronally on a freezing mic-
rotome at a thickness of 40 m and collected into six
adjacent bins. Tissue was then stored at 20°C in cryo-
protectant (30% sucrose, 30% ethylene glycol, 1%
polyvinyl-pyrrolidine [PVP-40]) until immunohistochemi-
cal processing was conducted.
To study the distribution of MCH-positive neurons, we
used rabbit anti-MCH serum (Phoenix Pharmaceuticals,
Burlingame, CA, cat. #: H-070-47, lot #: 00606). This an-
tibody was raised against full-length peptide (sequence:
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-
Tyr-Arg-Pro-Cys-Trp-Gln-Val) and has been shown to
have 100% cross-reactivity against MCH and 0% cross-
reactivity against orexins, agouti-related peptide, leptin,
-melanocyte-stimulating hormone, and neuropeptide Y
(manufacturer’s technical information).
To prevent nonspecific binding, tissue was first soaked
in blocking solution that consisted of 0.3% Triton X-100
(TX-100), 1% normal goat serum (NGS), and 1% bovine
serum albumin (BSA) in 0.1 M phosphate buffer (PB; pH
7.4). The antibody was then dissolved in the same blocking
mix and reacted with tissue at 1:10,000 or 1:15,000 for 1
hour at room temperature followed by 48 hours at 4°C.
The tissue was then reacted with biotinylated goat anti-
rabbit IgG (Vector, Burlingame, CA) at 1:200 in blocking
solution for 2 hours at room temperature. Following a
brief rinse in 0.1 M PB, the tissue was then reacted with
the VectaStain ABC System (Vector), with A and B re-
agents dissolved at 1:200 each in blocking solution. The
reaction was then visualized with 0.04% diaminobenze-
dine (DAB) as chromogen and 2  105 % H2O2 in 0.1 M
sodium acetate.
To verify the specificity of this antibody further, we
performed a blocking study in which adjacent sections
were incubated with the rabbit anti-MCH serum (as de-
scribed above) and with rabbit anti-MCH serum preincu-
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bated with 50 M of the MCH peptide (Phoenix Pharma-
ceuticals, cat. #: 070-47, lot #: 424859).
To study the distribution of orexin-synthesizing neu-
rons, we used an antibody raised against orexin-A. We
used rabbit polyclonal antibody (Abcam, Cambridge, MA,
cat. #: ab6214, lot #: 38610), which was raised against a
synthetic peptide (sequence: Cys-Arg-Leu-Tyr-Glu-Leu-
Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-
Leu), corresponding to amino acids 14–33 of cow orexin-A,
and conjugated to Lys-Leu-His by a glutaraldehyde linker
(manufacturer’s technical information). This peptide has
100% amino acid identity with rat orexin-A, and it con-
tains three regions of identity with orexin-B for a total of
13 identical amino acid residues between orexin-A and
orexin-B (Sakurai et al., 1998). This antibody has been
extensively tested to show that it cross-reacts to detect
both orexin-A and orexin-B and that it only stains orexin-
synthesizing neurons (Nambu et al., 1999). Tissue was
incubated with this antibody diluted to 1:5,000 and then
processed and visualized as described above.
Overview of tract-tracing studies
Male Sprague-Dawley rats (n  11; Charles River) were
used in tract-tracing studies. In these experiments we
employed transgenic recombinants of an attenuated pseu-
dorabies virus (PRV) strain, PRV-Bartha, for transneuro-
nal tracing of multisynaptic pathways innervating adre-
nal gland and gastrocnemius muscle. PRV has
preferential tropism for axonal terminals (Vahlne et al.,
1978, 1980). It is transported in the retrograde direction
from the terminals to the cell body where the viral genome
is replicated in the nucleus (Enquist et al., 1998). Capsids
are assembled and filled with viral DNA in the nucleus,
acquire the mature envelope from a late Golgi compart-
ment, and are transported to sites of afferent synaptic
contact, where cell-to-cell retrograde transneuronal trans-
mission of infection occurs (Card et al., 1993; Enquist et
al., 1998). The two viral recombinants that we employed
were PRV-152 and PRV-BaBlu. Both are derived from
PRV-Bartha, which is an attenuated form of the parental
strain, PRV-Becker. PRV-BaBlu contains the lac Z gene at
the gG locus and produces -galactosidase (-gal) under
the control of the viral gG promoter (Kim et al., 1999).
PRV-152 carries the gene coding for enhanced green flu-
orescent protein (eGFP) at the gG locus, which is consti-
tutively expressed under control of the cytomegalovirus
immediate early promoter (Smith et al., 2000). Previous
studies have demonstrated that PRV-152 and PRV-BaBlu
are transported transsynaptically in a retrograde manner,
similarly to PRV-Bartha and that the two recombinants
are capable of simultaneously co-infecting the same neu-
ronal population (Standish et al., 1995; Billig et al., 1999,
2000, 2001; Smith et al., 2000; Kerman et al., 2003,
2006a).
We previously reported a robust negative correlation
between the animal’s weight and efficiency of infection of
gastrocnemius motoneurons, with the largest rate of mo-
toneuron infection in rats of intermediate size that weigh
approximately 200 g (Kerman et al., 2003). Thus, animals
in the current study were selected to weigh between 163
and 254 g for an average of 197  8 g (mean  SEM).
Animals were anesthetized with either an inhalable or an
injectable anesthetic protocol. In the former case anesthe-
sia was induced with 5% isoflurane vaporized in 1–1.5
L/min of O2 and maintained with a 1.5–2.5% concentra-
tion. Alternatively, animals were injected i.p. with a mix
of ketamine and xylazine (60 mg/kg ketamine and 7 mg/kg
xylazine). Once a surgical plane of anesthesia was
achieved such that there was no spontaneous movement
and there were no withdrawal responses to tail and/or foot
pinch, hindlimb sympathectomy was performed.
In addition to somatic motor efferents, the hindlimb is
also innervated by sympathetic efferents that project to
blood vessels, sweat glands, and other smooth muscle
targets (Jänig and McLachlan, 1992). To prevent infection
of sympathetic pathways following injection of PRV-152
into the gastrocnemius muscle, the hindlimb was surgi-
cally sympathectomized in all animals by using a previ-
ously described approach (Kerman et al., 2003). Briefly,
the lumbar sympathetic nerve was dissected via a ventral
laparotomy and was extirpated from the level of the renal
artery caudal to the bifurcation of the abdominal aorta.
Neural plexuses running along the descending aorta and
inferior vena cava were also stripped off under microscopic
observation by using fine forceps. The abdominal aorta
and the inferior vena cava were then swabbed with 10–
20% phenol dissolved in ethylene glycol. The abdominal
musculature was closed with sutures, and the overlying
skin was closed with surgical staples. This procedure is
effective at removing the large majority of sympathetic
efferents to the hindlimb, as evidenced by the lack of
infection in the intermediolateral cell column in the same
animals that exhibited robust infections of lumbar mo-
toneurons (Kerman et al., 2003, 2006a,b).
Following sympathectomy and a 2–10-day recovery pe-
riod, the animals were reanesthetized and injected with
PRV-152 into either their right (n  2) or left (n  9)
gastrocnemius muscle. Following a 24–32-hour recovery
period, the same rats were reanesthetized and were in-
jected with PRV-BaBlu into their left adrenal glands.
Choice of anesthetic regime had no effect on viral infection
or transport.
At the conclusion of the survival period following trans-
port of viral tracers, animals were deeply anesthetized
with 1 ml i.p. of 50 mg/ml pentobarbital sodium solution
and transcardially perfused with 100–150 ml of physio-
logical saline followed by 400–500 ml of a 4% paraformal-
dehyde solution containing 1.4% l-lysine and 0.2% sodium
meta-periodate (PLP) (McLean and Nakane, 1974).
Double-virus injections
Viral recombinants used in the present studies were
harvested from pig kidney cell cultures at a titer of 108 to
109 pfu/ml. Viral stocks were aliquoted in 50-l volumes
and stored at 80°C. At the times of injection viral ali-
quots were removed from the freezer and kept on ice until
immediately before injections.
To determine the location of neurons coordinating mus-
cle contraction and autonomic activity, rats received injec-
tions of PRV-152 into their gastrocnemius muscles and
injections of PRV-BaBlu into their adrenal glands. In each
animal the gastrocnemius muscle was injected with 30 l
of PRV-152, which was divided into multiple injections of
1.0 l. The adrenal gland was dissected via a left flank
incision and gently separated from surrounding viscera
and fat; the adjacent connective tissue was then retracted
to facilitate access to the gland. Two or three injections of
PRV-BaBlu were then made into the gland through a
glass pipette attached to a 10-l Hamilton syringe; the
total volume of virus injected was 2–4 l. Following each
The Journal of Comparative Neurology. DOI 10.1002/cne
588 I.A. KERMAN ET AL.
injection the gland was swabbed with a cotton-tip appli-
cator to decrease nonspecific viral spread. We previously
demonstrated that this injection protocol produces an ef-
ficient infection of target neurons and does not result in
spread of virus to non-target tissues (Kerman et al., 2003).
Injected animals were assigned to one of three groups:
short, intermediate, and long survival times. In the short
survival group (n  3) rats survived for 121–122 hours
following injection with PRV-152 and for 96–97 hours
following PRV-BaBlu injection. We chose this survival
time point because this is the earliest time point at which
appreciable numbers of double-infected neurons are de-
tected in the rat hypothalamus (Kerman et al., 2006a).
Because a single replication cycle of the virus is 10–12
hours (Demmin et al., 2001), we therefore decided to ex-
tend the survival times by 10–12 hours to determine the
maximal number of double-infected neurons that express
MCH and orexins. Accordingly, in the intermediate sur-
vival group (n  4) the animals survived for 132 or 136
and 108 or 112 hours following injections with PRV-152
and PRV-BaBlu, respectively. In the late survival group
(n  4) the animals survived for 143–144 and 111–120
hours following injections with PRV-152 and PRV-BaBlu,
respectively.
Tissue processing
Following transcardial perfusion with PLP (see above),
the entire brain was extracted and postfixed in PLP over-
night. Brains were then immersed in 20% sucrose until
they sank to the bottom of the container; they were sec-
tioned coronally on a freezing microtome at a thickness of
35 or 40 m and collected into six bins. Tissue was stored
at 20°C in cryoprotectant until immunohistochemical
processing was conducted.
For immunofluorescent detection in the brain, tissue
was initially rinsed with 0.1 M PB several times at room
temperature. It was then incubated for 1 hour in the
blocking solution (1% NGS, 1% BSA, and 0.3% TX-100 in
0.1 M PB). Sections were then reacted with a cocktail of
primary antibodies—chicken anti-GFP IgY (Abcam, prod-
uct # 13970) at 1:2,000, mouse anti--gal IgG (Sigma, St.
Louis, MO, product # G4644) at 1:1,000, and either rabbit
anti-MCH at 1:10,000 or rabbit anti-orexin at 1:500—
diluted in the above blocking solution. In each animal
adjacent tissue bins were processed for orexin, GFP, -gal
triple-labeling and for MCH, GFP, -gal triple-labeling.
The chicken anti-GFP antibody was raised against recom-
binant full-length protein. This antibody yields a single
band on Western blot and detects GFP in transgenic mice
expressing GFP in lamina II of the spinal cord (manufac-
turer’s technical information). We have previously deter-
mined absence of staining with this antibody in uninfected
rat tissue sections (Kerman et al., 2006b). Mouse anti--
gal antibody was developed in mouse peritoneal cavities
by using -gal purified from E. coli as the immunogen.
Using Western blot, this antibody was shown to be specific
for -gal in its native form (116 kDa), and it reacts only
with -gal from E. coli (manufacturer’s technical informa-
tion). The specificity of this antibody in immunofluores-
cent experiments has been previously documented (Ker-
man et al., 2003).
Following 48-hour incubation at 4°C in the primary
antibody solution, the tissue was rinsed several times
with 0.1 M PB and then reacted with a secondary antibody
solution, which consisted of donkey anti-mouse IgG con-
jugated to CY3 (1:200; Jackson ImmunoResearch, West
Grove, PA), goat anti-chicken IgG conjugated to Alexa
Fluor 488 (1:200; Molecular Probes Invitrogen, Carlsbad,
CA), and goat anti-rabbit IgG conjugated to Alexa Fluor
647 (1:200; Molecular Probes Invitrogen) dissolved in the
blocking solution (1% NGS, 1% BSA, and 0.3% TX-100).
Following processing, tissue sections were mounted on
glass slides and coverslipped with Aqua Poly/Mount (Poly-
sciences, Warrington, PA).
Tissue analysis
Images of antibody-labeled MCH and orexin-
synthesizing neurons were taken at 10 magnification
with a flat-field correction by using a Zeiss Axiophot up-
right light microscope (Carl Zeiss MicroImaging, Thorn-
wood, NY), operated by a Ludl motorized stage that was
connected to a Ludl MAC2000 XYZ controller module
(Ludl Electronic Products, Hawthorne, NY). Images of
individual fields of view were stitched together by using
the virtual slice tool in Stereo Investigator software (Mi-
croBrightField, Williston, VT) on a Dell PC.
Immunofluorescently labeled tissue was examined by
using a Leica DMR photomicroscope (Wetzlar, Germany)
and with an Olympus FluoView 1000 laser scanning
confocal microscope (http://www.olympusfluoview.com/).
Swanson’s (2004) rat atlas was used as a reference for
anatomical classification. When using Leica DMR micro-
scope, the presence of each fluorophore was detected by
using specific filter sets (Chroma Technology, Brattleboro,
VT) with the following respective excitation and emission
ranges: Alexa Fluor 488, 440–520 nm and 500–555 nm
(green fluorescence); CY3, 535–560 nm and 545–625 nm
(red fluorescence); and Alexa Fluor 647, 560–680 nm and
625–775 nm (far red fluorescence).
Adjacent black-and-white images of the LH were digi-
tized under a 20 objective; images were then stitched
together by using the Photomerge function in Adobe Pho-
toshop CS (Adobe Systems, San Jose, CA). Each of these
large stitched images corresponded to a different fluores-
cent filter set and was pseudocolored as follows: GFP-
positive neurons, green; -gal-containing cells, red; and
MCH- or orexin-positive neurons, blue or cyan. These
pseudocolored images were then overlaid, and co-
localization of two or three fluorophores was determined
by turning each layer on and off to determine location and
color of each cell. Brightness and contrast of images were
optimized for presentation purposes, and figures were pre-
pared in Photoshop.
Statistical analyses
Potential differences in distribution of labeled neurons
between perifornical and peripeduncular regions were
evaluated with repeated measures ANOVA with region
(perifornical vs. peripeduncular) and anatomical level as
independent variables and percentage of cells that were
either MCH-positive PSPMNs or orexin-positive PSPMNs
as a dependent variable. Statistical analyses were carried
out in StatView 5.0 (SAS Institute, Cary, NC), and signif-
icance was set as P  0.05.
RESULTS
Specificity of the MCH antibody
To confirm the specificity of the MCH antibody, we
performed a blocking study with the specific MCH peptide.
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In this experiment, sections through the LH were reacted
with the anti-MCH antibody with and without preincuba-
tion of MCH peptide. Under control conditions we detected
robust labeling in LH around the cerebral peduncle (Fig.
1A). The observed MCH antibody labeling was completely
abolished by preincubation with the MCH peptide (Fig.
1B), thus confirming the specificity of this antibody for
MCH.
Distribution of MCH- and orexin-
synthesizing neurons
Distribution of MCH- and orexin-synthesizing neurons
was studied in sections from adjacent (1 in 6 series) bins
that were visualized by using DAB as the chromogen.
These studies demonstrated that although MCH-positive
neurons were distributed throughout LH, they formed two
clear groupings. The first cluster of MCH neurons was
located around the fornix (perifornical region), whereas
the second cluster of these cells was found around the
cerebral peduncle (peripeduncular region). Figure 2A–C
demonstrates this distribution pattern of MCH-positive
neurons in LH. Note the clustering of neurons in the
perifornical and peripeduncular regions, which is espe-
cially prominent at the caudal level that we examined
(Fig. 2A).
Although orexin-positive neurons occupied a similar
area within LH, it was apparent that the bulk of these
neurons was located more medially than the MCH-
positive cells. Figure 2D–F illustrates the distribution of
orexin-positive cells; note that these neurons are prefer-
entially distributed within the perifornical region com-
pared with the peripeduncular region. Within the perifor-
nical region, orexin-positive cells also appeared to be more
prevalent than the MCH-positive cells (compare the label-
ing in Fig. 2F with that in Fig. 2C).
Expression of MCH within PSPMNs
In line with our previous observations (Kerman et al.,
2006a), we detected considerable numbers of double-
infected neurons within LH and DMH across all three
survival groups. Within LH these neurons were equally
distributed throughout the nucleus and were as likely to
be located in the perifornical region as in the peripedun-
cular region.
We conducted triple-labeling experiments aimed at de-
termining whether hypothalamic PSPMNs expressed
MCH. In these experiments MCH-positive neurons were
tagged with a far red fluorophore and were pseudocolored
cyan. Cells that send polysynaptic projections to hindlimb
muscle were tagged with a green fluorophore, and those
that send polysynaptic projections to the adrenal gland
were tagged with a red fluorophore. Thus, double-infected
neurons appeared yellow, whereas triple-labeled neurons
appeared as a mixture of all three colors.
Figure 3 illustrates examples of neurons infected with
PRV-152 (green), or PRV-BaBlu (red), or both (yellow) and
their relationship to the MCH-synthesizing neurons
(cyan). We detected MCH within PSPMNs throughout LH;
however, these triple-labeled cells appeared to be more
numerous within the peripeduncular region (Fig. 3D2)
than within the perifornical region (Fig. 3D1).
We then mapped the locations of MCH-positive
PSPMNs, as well as the locations of neurons that were
infected with only one PRV strain but also expressed
MCH. These maps were created at three different rostro-
caudal levels of the rat hypothalamus and across the three
different survival periods used in the current study. Fig-
ure 4 illustrates the distributions of these cells at different
survival times. Note that at the earliest survival time
there are considerable numbers of PSPMNs in LH and
DMH (Fig. 4A). Some of these neurons express MCH
(black circles) and are intermingled with MCH-negative
PSPMNs (yellow squares). Furthermore, these neurons
are present around the fornix (in the perifornical region)
and around the cerebral peduncle (in the peripeduncular
region).
With increased survival time, the numbers of detected
double-infected neurons increased and these cells were
present throughout LH and DMH. However, with these
longer survival times MCH-positive PSPMNs (black cir-
cles) segregated preferentially toward the peripeduncular
region (Fig. 4B,C).
Expression of orexins within PSPMNs
We conducted triple-labeling experiments to determine
whether hypothalamic PSPMNs are orexinergic. In these
Fig. 1. Characterization of the MCH antiserum. Specificity was
ascertained by performing a blocking study. Adjacent sections were
incubated with the MCH antibody alone (A) or with MCH antibody
preincubated with MCH peptide (B). Note robust labeling in A and
absence of labeling in B, indicating specificity of the antibody binding.
Scale bar  50 m in B (applies to A,B).
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experiments orexin-positive neurons were tagged with a far
red fluorophore and pseudocolored cyan. Neurons that send
polysynaptic projections to hindlimb muscle were tagged
with a green fluorophore, whereas those sending polysynap-
tic projections to the adrenal gland were tagged with a red
fluorophore. Figure 5 illustrates data from these experi-
ments; note that in these examples the numbers of orexin-
positive PSPMNs are greater within the perifornical area
(Fig. 5D1) compared with the peripeduncular area (Fig. 5D2).
As with the MCH-positive neurons, we mapped the lo-
cations of orexin-positive PSPMNs in relation to the
orexin-negative double-infected neurons as well as to
orexin-positive single-infected neurons (Fig. 6). This map-
ping revealed that orexin-positive PSPMNs were detected
even at the earliest survival time point and that the num-
bers of double-infected cells increased with longer survival
times. Furthermore, as the numbers of PRV-infected neu-
rons increased with increasing survival, orexin-positive
Fig. 2. Distribution of MCH- and orexin-positive neurons. Distri-
bution of these neurons was examined at three rostrocaudal levels:
approximately 3.80 mm (A,D; level 1), 3.25 mm (B,E; level 2), and
2.50 mm (C,F; level 3) from bregma. MCH-positive neurons are
shown on the left (A–C), and orexin-positive neurons are shown on the
right (D–F). Note the clustering of MCH-positive neurons around the
fornix and at the medial edge of the cerebral peduncle, which is
especially pronounced at the caudalmost level (A). Although orexin-
ergic neurons are distributed throughout the lateral hypothalamus,
they tend to cluster in the perifornical region. This is especially
prominent at the rostralmost level (F). Abbreviations: 3v, third ven-
tricle; cpd, cerebral peduncle; fx, fornix; mtt, mammillothalamic tract;
ot, optic tract. Scale bar  300 m in D (applies to A–F).
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Fig. 3. Co-localization of viral reporter genes with melanin-
concentrating hormone (MCH) in neurons of the lateral hypothala-
mus. Triple-labeled sections were imaged with a laser-scanning con-
focal microscope taking 40–60 optical sectioins per field of view. For
each image the z-stack was compressed, and images were rendered for
three-dimensional representation. A1,A2: MCH-positive neurons
were tagged with Alexa Fluor 647 and pseudocolored with cyan.
B1,B2,C1,C2: Hypothalamic neurons that send polysynaptic projec-
tions to hindlimb muscle were infected with pseudorabies virus
(PRV)-152, tagged with Alexa Fluor 488, and pseudocolored with
green (B1,B2); neurons with polysynaptic projections to the adrenal
gland were infected with PRV-BaBlu, tagged with CY3, and pseudo-
colored with red (C1,C2). D1,D2: Merged images of A1–C2.
A1–D1: Images from the perifornical region (note the edge of the
fornix outlined with a dashed line). A2–D2: Images from the peripe-
duncular region. Triple-labeled neurons (MCH-positive PSPMNs) are
shown with arrows. An MCH-positive neuron that was infected only
with PRV-BaBlu is shown with thick arrows in A2–D2, and an MCH-
positive neuron that was infected only with PRV-152 is shown with
long narrow arrows in A2–D2. Double-infected neurons that are
MCH-negative are shown with arrowheads. Note greater numbers of
triple-labeled neurons in the peripeduncular region (2) compared with
the perifornical region (1). Abbreviation as in Figure 2. Each box of the
grid is 32 m.
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PSPMNs preferentially clustered within the perifornical
region of LH (Fig. 6B,C).
Comparison of the distribution of MCH- and
orexin-positive PSPMNs
To compare the distribution of MCH- and orexin-
positive PSPMNs directly, double-infected neurons that
were positive for each of these peptides were mapped onto
corresponding atlas plates from Swanson’s (2004) rat brain
atlas. Figure 7 illustrates data from this mapping study; at
each survival time point MCH- and orexin-positive PSPMNs
were projected onto the same atlas plate (plate #30 in Swan-
son’s (2004) rat brain atlas. These data demonstrate a clear
segregation of MCH- (red dots) and orexin- (blue dots) syn-
thesizing PSPMNs into lateral and medial clusters, respec-
tively. This clustering is apparent at intermediate (Fig. 7B)
and long (Fig. 7C) survival time points.
To determine whether this segregation into medial and
lateral groups of orexin- and MCH-positive PSPMNs is
true throughout the rostrocaudal extent of LH, we per-
formed the same mapping procedure at three different
rostrocaudal levels for data collected from two of the long-
surviving animals. Figure 8 illustrates results from this
study; these data also indicate segregation of MCH- and
orexin-positive PSPMNs into lateral and medial groups
within LH.
Quantification
To determine regional differences in the distribution of
PRV-infected neurons, we quantified the numbers of: 1)
Fig. 4. Distribution of MCH- and PRV-containing neurons in the
hypothalamus. Anatomical landmarks were traced from original sec-
tions, and locations of virus-infected cells were plotted onto these
maps. Only one hemisection is presented from each level, but the
pattern of labeling was symmetrical. Each symbol represents one
neuron on the actual section. Yellow squares represent neurons co-
infected with PRV-152 (polysynaptic projections to hindlimb muscle)
and PRV-BaBlu (polysynaptic projections to adrenal gland). Black
circles represent neurons co-infected with PRV-152 and PRV-BaBlu
that also express MCH. Red triangles represent MCH-containing
neurons that are infected only with PRV-BaBlu, and aqua diamonds
indicate MCH-containing neurons infected only with PRV-152. Label-
ing was examined at three rostrocaudal levels (similar to the ones
represented in Figure 2: 1, caudal; 2, intermediate; 3, rostral. Panels
on the left (A1–A3) are from an animal in the short survival group,
those in the middle (B1–B3) are from an animal in the intermediate
survival group, and those on the right (C1–C3) are from an animal in
the long survival group. Note that although double-infected neurons
are distributed throughout the lateral and dorsomedial hypothala-
mus, PSPMNs that express MCH are preferentially distributed in the
peripeduncular region (along the medial edge of cerebral peduncle).
This is especially prominent at longer survival time points (for exam-
ple, C2). Abbreviations as in Figure 2.
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Fig. 5. Co-localization of viral reporter genes with orexin in neu-
rons of the lateral hypothalamus. Triple-labeled sections were imaged
with a laser-scanning confocal microscope taking 40–60 optical sec-
tions per field of view. For each image the z-stack was compressed,
and images were rendered for three-dimensional representation.
A1,A2: Orexin-positive neurons were tagged with Alexa Fluor 647
and pseudocolored with cyan. B1,B2,C1,C2: Hypothalamic neurons
that send polysynaptic projections to hindlimb muscle were infected
with pseudorabies virus (PRV)-152, tagged with Alexa Fluor 488, and
pseudocolored with green (B1,B2); neurons with polysynaptic projec-
tions to the adrenal gland were infected with PRV-BaBlu, tagged with
CY3, and pseudocolored with red (C1,C2). D1,D2: Merged images of
A1–C2. A1–D1: Images from the perifornical region (note the edge of
the fornix outlined with a dashed line). A2–D2: Images from the
peripeduncular region. Triple-labeled neurons (orexin-positive
PSPMNs) are shown with arrows. Double-infected neurons that are
orexin-negative are shown with arrowheads. Thick arrows in A1–D1
and A2–D2 show orexin-positive neurons that were infected only with
PRV-BaBlu. Note greater numbers of triple-labeled neurons in the
perifornical region (1) compared with the peripeduncular region (2).
Images were taken from the same animal as shown in Figure 4.
Abbreviation as in Figure 2. Each box of the grid is 32 m.
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double-infected neurons that were MCH- or orexin-nega-
tive; 2) double-infected neurons that were MCH- or orexin-
positive; and 3) neurons that were infected with only one
of the PRV strains and were either MCH- or orexin-
positive. This procedure was carried out in tissue obtained
from three rats from the intermediate survival time point.
This survival time was chosen because it is the first time
point at which appreciable numbers of double-infected
neurons are detected that probably send direct projections
to the spinal cord. Quantification was performed on sec-
tions from three different anatomical levels, as illustrated
in Figure 2.
Digitized tissue sections were marked up with different
symbols representing these combinations of markers (see
Figs. 4 and 6 for examples). These maps were then pro-
jected onto digital plates from the Swanson’s (2004) rat
atlas, and symbols were counted within the different hy-
pothalamic nuclei (Tables 1, 2). Based on Swanson’s atlas,
the following LH subnuclei were grouped together to rep-
resent the peripeduncular region: dorsal region; ventral
region, lateral zone; ventral region, medial zone; magno-
cellular nucleus; and parvicellular region. In addition, the
preparasubthalamic nucleus was also included in the
peripeduncular region. For the perifornical region, the
posterior hypothalamus was included as well as the fol-
lowing LH subnuclei: juxtadorsomedial; suprafornical;
juxtaventromedial region, dorsal zone; and juxtaventro-
medial region, ventral zone.
To evaluate potential differences in the distribution of
MCH-positive PSPMNs between perifornical and peripe-
duncular regions, cell counts for each anatomical level in
each animal were expressed as percentage of total neu-
Fig. 6. Distribution of orexin- and PRV-containing neurons in the
hypothalamus. Anatomical landmarks were traced from original sec-
tions, and locations of virus-infected cells were plotted onto these
maps. Only one hemisection is presented from each level, but the
pattern of labeling was symmetrical. Each symbol represents one
neuron on the actual section. Yellow squares represent neurons co-
infected with PRV-152 (polysynaptic projections to hindlimb muscle)
and PRV-BaBlu (polysynaptic projections to adrenal gland). Black
circles represent neurons co-infected with PRV-152 and PRV-BaBlu
that also express orexin. Red triangles indicate orexin-containing
neurons that are infected only with PRV-BaBlu, and aqua diamonds
indicate orexin-containing neurons infected only with PRV-152. La-
beling was examined at three rostrocaudal levels similar to the ones
represented in Figure 2: 1, caudal; 2, intermediate; 3, rostral. Panels
on the left (A1–A3) are from an animal in the short survival group,
those in the middle (B1–B3) are from an animal in the intermediate
survival group, and those on the right (C1–C3) are from an animal in
the long survival group. Note that although double-infected neurons
are distributed throughout the lateral and dorsomedial hypothala-
mus, orexin-positive PSPMNs are preferentially distributed in the
perifornical region (e.g., in C2). Abbreviations as in Figure 2.
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rons that were detected (these included MCH-positive
PSPMNs, MCH-negative PSPMNs, and neurons that were
infected with only one of the PRV strains and expressed
MCH). Figure 9A illustrates these data. Potential differ-
ences in the distribution of MCH-positive PSPMNs be-
tween perifornical and peripeduncular subdivisions were
evaluated with repeated measures ANOVA with region
(peripeduncular vs. perifornical) and anatomical level as
independent variables and percentage of cells as a depen-
dent variable. The ANOVA revealed significant differ-
ences in distribution of cells by region (F  23.390, df 1, 8,
P  0.01), and no effects of level (P 	 0.1) or level by region
interaction (P 	 0.1).
To evaluate potential differences in the distribution of
orexin-positive PSPMNs between perifornical and peripe-
duncular regions, cell counts for each anatomical level in
each animal were expressed as percentage of total neu-
rons that were detected (these included orexin-positive
PSPMNs, orexin-negative PSPMNs, and neurons that
were infected with only one of the PRV strains and ex-
pressed orexin). Figure 9B illustrates these data. Poten-
tial differences in the distribution of orexin-positive
PSPMNs between perifornical and peripeduncular subdi-
visions were evaluated with repeated measures ANOVA
with region (peripeduncular vs. perifornical) and anatom-
ical level as independent variables and percentage of cells
as a dependent variable. The ANOVA revealed significant
differences in distribution of cells by region (F  16.414, df
1, 8, P  0.05), and no effects of level (P 	 0.1) or level by
region interaction (P 	 0.1).
DISCUSSION
In the current paper we focused our attention on hypo-
thalamic PSPMNs. Neurons with putative dual (sympa-
thetic and somatomotor) functions were identified by in-
jecting distinct PRV recombinants into hindlimb muscle
and the adrenal gland. Based on our previous reports on
the anatomical distribution of the hypothalamic PSPMNs,
we hypothesized that a subset of these neurons would be
MCH- or orexin-positive. To test this hypothesis, we car-
ried out triple-labeling experiments in which we combined
immunofluorescent detection of viral reporter genes with
that of orexins and MCH. Our results demonstrate that
dual-infected neurons synthesize both orexins (Figs. 5, 6)
and MCH (Figs. 3, 4). Previous studies have demonstrated
that orexin- and MCH-positive neurons constitute sepa-
rate but intermixed populations (Broberger et al., 1998;
Elias et al., 1998; Swanson et al., 2005); thus MCH- and
orexin-positive PSPMNs comprise separate neuronal pop-
Fig. 7. Spatial segregation of melanin-concentrating hormone
(MCH)- (red) and orexin- (blue) positive presympathetic-premotor
neurons (PSPMNs). Each dot represents one neuron. Dual-infected
neurons that were also MCH- or orexin-positive from adjacent sec-
tions were projected onto the same section taken from Swanson’s rat
brain atlas (plate #30, Swanson, 2000). A: Data taken from one
animal in the short survival group. B: Data from two animals in the
intermediate survival group. C: Data from two animals in the long
survival group. Note that although there is some intermixing between
the two populations, the majority of the two types of neurons are
spatially segregated. Melanin-concentrating hormone (MCH)-positive
presympathetic-premotor neurons (PSPMNs) are distributed more
laterally and closer to the medial edge of the cerebral peduncle,
whereas orexin-positive PSPMNs are distributed more medially
around the fornix and in the dorsomedial hypothalamus. Abbrevia-
tions: ARH, arcuate hypothalamic nucleus; COApm, cortical amyg-
dalar nucleus, posterior part, medial zone; DMHa, dorsomedial hypo-
thalamic nucleus, anterior part; DMHp, dorsomedial hypothalamic
nucleus, posterior part; DMHv, dorsomedial hypothalamic nucleus,
ventral part; fx, fornix; I, internuclear part, hypothalamic periven-
tricular region; LHA, lateral hypothalamic area; LHAd, lateral hypo-
thalamic area, dorsal region; LHAjd, lateral hypothalamic area, jux-
tadorsomedial region; LHAjvv, lateral hypothalamic area,
juxtaventromedial region, ventral zone; LHAm, lateral hypothalamic
area, magnocellular nucleus; LHAs, lateral hypothalamic area, su-
prafornical region; LHAsfp, lateral hypothalamic area, subfornical
region, posterior zone; LHAvl, lateral hypothalamic area, ventral
region, lateral zone; LHAvm, lateral hypothalamic area, ventral re-
gion, medial zone; MEex, median eminence, external lamina; mtt,
mammillothalamic tract; PH, posterior hypothalamic nucleus; PR,
perireuniens nucleus; PVi, periventricular hypothalamic nucleus, in-
termediate part; STN, subthalamic nucleus; TUi, tuberal nucleus,
intermediate part; TUl, tuberal nucleus, lateral part; TUsv, tuberal
nucleus, subventromedial part; TUte, tuberal nucleus, terete subnu-
cleus; V3h, third ventricle, hypothalamic part; vlt, ventrolateral hy-
pothalamic tract; VMHc, ventromedial hypothalamic nucleus, central
part; VMHvl, ventromedial hypothalamic nucleus, ventrolateral part;
ZI, zona incerta.
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ulations. Our data are consistent with this interpretation
and extend it further by demonstrating that orexin- and
MCH-positive PSPMNs are spatially segregated. Accord-
ingly, such orexin-positive neurons are distributed mainly
within the perifornical region of LH, whereas MCH-
positive PSPMNs are found primarily within its peripe-
duncular subdivision.
Antibody specificity
For data interpretation it is important to consider first
the specificity of the antibodies that were used in the
current study. In regard to the antibodies used to detect
viral reporter genes, we have previously confirmed their
specificities by demonstrating absence of staining in non-
infected rat brain tissue (Kerman et al., 2003, 2006a).
Furthermore, the orexin antiserum employed in this cur-
rent study has been extensively characterized by Nambu
and co-workers (1999). As part of their study these au-
thors demonstrated that preincubation of the serum with
orexins, but not with neuropeptide Y or angiotensin, abol-
ishes the signal (Nambu et al., 1999). Furthermore, they
demonstrated staining with this antibody in cells trans-
fected with prepro-orexin cDNA but not in the mock trans-
fected cells (Nambu et al., 1999). Although we did not
carry out such controls in our study, the pattern of distri-
bution of orexinergic neurons that we observed in our
material (Fig. 2D–F) was consistent with a previous de-
scription using both immunocytochemistry and in situ
hybridization (Elias et al., 1998; Sakurai et al., 1998;
Nambu et al., 1999; Swanson et al., 2005); thus we can be
Fig. 8. Spatial segregation of MCH- (red) and orexin- (blue) posi-
tive PSPMNs. The layout of the figure is similar to that of Figure 8,
except multiple sections from Swanson’s (2004) rat brain atlas are
represented. A–C: Data are shown rostral (A) to caudal (C), with A
corresponding to plate 28 of the atlas, B corresponding to plate 30, and
C corresponding to plate 32. Data were taken from two animals at the
long survival time. Note the spatial segregation of the two populations
of PSPMNs, with MCH-positive cells lying more laterally and orexin-
positive cells distributed more medially. Abbreviations: AL, pituitary
gland, anterior lobe; DGlb, dentate gyrus, lateral blade; DGlb-sg,
dentate gyrus, lateral blade-granule cell layer; LHAsfpm, lateral hy-
pothalamic area, subfornical region, permammillary zone; NL, pitu-
itary gland, neural lobe; PMd, dorsal premammillary nucleus; PMv,
ventral premammillary nucleus; PSTN, parasubthalamic nucleus;
PVp, periventricular hypothalamic nucleus, posterior part; SUB, sub-
iculum; TMd, tuberomammillary nucleus, dorsal part. For other ab-
breviations, see Figure 7 legend.
TABLE 1. Number of Neurons Infected With PRV and Their Co-
Localization With MCH at the Intermediate Survival Time Point Within
the Peripeduncular and Perifornical Regions of the Lateral Hypothalamus1
Anatomical
level Label Peripeduncular Perifornical
1 MCH
PRV-152
PRV-BaBlu 11.7  7.7 2.0  2.0
PRV-152
PRV-BaBlu 5.7  3.2 5.0  5.0
MCH
PRV-BaBlu 1.7  0.9 0
MCH
PRV-152 7.3  3.2 1.0  1.0
2 MCH
PRV-152
PRV-BaBlu 15.0  6.5 0.7  0.3
PRV-152
PRV-BaBlu 10.7  2.3 17.3  4.2
MCH
PRV-BaBlu 3.3  1.7 0
MCH
PRV-152 7.7  3.4 1.3  0.7
3 MCH
PRV-152
PRV-BaBlu 12.3  3.2 3.3  1.2
PRV-152
PRV-BaBlu 10.7  0.9 13.7  5.9
MCH
PRV-BaBlu 2.7  1.2 1.0  0.6
MCH
PRV-152 8.3  4.9 1.7  1.2
1Data are totals from three animals sacrificed at the intermediate survival time point.
Anatomical levels 1, 2, and 3 refer to anatomical levels illustrated in Figure 2. Data are
presented as mean  SEM. See text for additional details. Abbreviations: MCH,
melanin-concentrating hormone; PRV, pseudorabies virus.
TABLE 2. Number of Neurons Infected with PRV and Their Co-
Localization With Orexin at the Intermediate Survival Time Point Within
the Peripeduncular and Perifornical Regions of the Lateral Hypothalamus1
Anatomical
level Label Peripeduncular Perifornical
1 Orexin
PRV-152
PRV-BaBlu 2.7  1.8 6.7  2.7
PRV-152
PRV-BaBlu 18  7.6 10.7  6.2
Orexin
PRV-BaBlu 0.7  0.7 1.0  0.6
Orexin
PRV-152 7.0  4.2 4.0  2.0
2 Orexin
PRV-152
PRV-BaBlu 4.3  3.0 10.0  2.0
PRV-152
PRV-BaBlu 14.0  10.0 19.0  4.0
Orexin
PRV-BaBlu 0.3  0.3 4.7  1.3
Orexin
PRV-152 5.7  2.3 2.3  0.3
3 Orexin
PRV-152
PRV-BaBlu 1.7  1.2 7.0  3.1
PRV-152
PRV-BaBlu 6.0  3.1 6.7  1.2
Orexin
PRV-BaBlu 0.7  0.3 1.3  0.7
Orexin
PRV-152 1.7  0.7 5.7  3.7
1Data are totals from three animals sacrificed at the intermediate survival time point.
Anatomical levels 1, 2, and 3 refer to anatomical levels illustrated in Figure 2. Data are
presented as mean  SEM. See text for additional details. Abbreviation: PRV, pseu-
dorabies virus.
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confident of the specificity of the orexin antiserum used in
the present study.
The pattern of labeling that we observed with the MCH
antibody used in the current study (Fig. 2A–C) was like-
wise similar to the pattern of distribution of this peptide
that was previously described (Bittencourt et al., 1992;
Elias et al., 1998; Swanson et al., 2005). We further veri-
fied the specificity of this antibody by performing a block-
ing study (Fig. 1) in which the antiserum was preincu-
bated with the MCH peptide. Data from this experiment
demonstrated the specificity of this antibody as the stain-
ing was completely abolished by the preincubation. Thus,
we are also confident of the specificity of the MCH anti-
serum used in this study.
Connectional considerations
It is likely that at least some of the double-infected
neurons that we identified in the present study send direct
projections to the spinal cord. The presence of such neu-
rons at the earliest survival time in our study is consistent
with this notion. Furthermore, the presence of spinally
projecting neurons in LH has also been demonstrated by
using retrograde tract tracers (Hosoya, 1980; Haring and
Davis, 1983; Kohler et al., 1984; Shiosaka et al., 1985;
Porter and Brody, 1986). Therefore, it seems feasible that
such hypothalamospinal neurons collateralize to inner-
vate simultaneously adrenal sympathetic preganglionic
neurons and lumbar motoneurons. This hypothesis is sup-
ported by anatomical investigations that demonstrated
the existence of heavy density of orexinergic fibers in the
intermediolateral column of the spinal cord and moderate
density of these fibers in the ventral horn (van den Pol,
1999). The presence of MCH-immunoreactive fibers in the
intermediolateral cell column and the lumbar ventral
horn of the spinal cord has also been demonstrated (Bit-
tencourt and Elias, 1998). Nonetheless, definitive demon-
stration of such collateralized projections directly from LH
to the spinal cord requires further investigation.
In addition to the direct projections to the spinal cord,
LH also contains neurons with projections to the lower
brainstem. Among them are neurons that innervate the
ventromedial medulla (Hosoya, 1985), which is the most
likely site of this relay because this area contains the
greatest numbers of the caudally located PSPMNs (Ker-
man et al., 2003, 2006b). Thus, it is likely that at least
some of the double-infected neurons that we observed at
longer survival times synapse on neurons in the ventro-
medial medulla, which in turn send descending projec-
tions to the spinal cord.
One of the major findings of the present study is the
spatial separation of orexin- and MCH-positive PSPMNs.
The orexinergic dual-infected neurons were more likely to
be distributed medially within LH in the perifornical re-
gion, whereas MCH-positive PSPMNs were more likely to
be found closer to the medial edge of the cerebral peduncle
(see Figs. 7 and 8). This finding is supported by traditional
tract-tracing approaches using retrogradely transported
fluorescent dyes to study ascending and descending pro-
jections from LH (Bittencourt and Elias, 1998). Bitten-
court and Elias (1998) showed that descending MCH-
positive neurons were distributed laterally within LH
along the medial edge of the cerebral peduncle, whereas
the ascending neurons were distributed more medially
within the perifornical region (see Fig. 6 of their paper).
Cvetkovic and colleagues (2004) have also demonstrated
that MCH neurons express neurokinin-3 receptor and
cocaine- and amphetamine-regulated transcript (CART).
However, a distinct cluster of MCH neurons just medial to
the cerebral peduncle does not express these markers
(Cvetkovic et al., 2004). Based on their previous observa-
tions that neurokinin-3 receptor-negative MCH neurons
send descending projections to the spinal cord, whereas
neurokinin-3 receptor-positive neurons send ascending
projections (Brischoux et al., 2002), these authors pro-
posed parcellation of MCH neurons into two categories.
According to this scheme, class A neurons are
neurokinin-3 receptor- and CART-negative and have de-
scending projections, whereas class B neurons are
neurokinin-3 receptor- and CART-positive and have as-
cending projections (Cvetkovic et al., 2004). The finding
that spinally projecting class A MCH neurons are located
just medial to the cerebral peduncle strongly supports our
current observation of clustering of MCH-positive
PSPMNs in the peripeduncular LH.
Previous studies have also demonstrated that LH neu-
rons sending polysynaptic projections to a variety of auto-
nomically innervated targets synthesize orexins. For ex-
ample, Geerling and colleagues (2003) demonstrated the
presence of orexin double-labeled neurons within LH fol-
Fig. 9. Distribution of melanin-concentrating hormone (MCH)- (A)
and orexin- (B) positive presympathetic-premotor neurons (PSPMNs)
within perifornical and peripeduncular subregions. For each animal
the numbers of triple-labeled neurons within the two subdivisions
were expressed as percentages of the total number of neurons that
were detected. These values were averaged and are presented as
mean  SEM. Levels 1, 2, and 3 refer to anatomical levels illustrated
in Figure 2. Differences in the distribution of triple-labeled neurons
between perifornical and peripeduncular regions were statistically
significant for MCH and orexin: A (MCH-positive PSPMNs), P  0.01,
repeated measures ANOVA; B (orexin-positive PSPMNs), P  0.05,
repeated measures ANOVA. See text for additional details.
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lowing PRV injections into stellate and celiac sympathetic
ganglia, as well as following its injection into the adrenal
gland and kidney. Closer examination of their data sug-
gests that such double-labeled neurons tend to cluster
more around the fornix than other areas in LH (see Figs.
1 and 2 in Geerling et al., 2003), which is consistent with
our findings. Furthermore, a study by Krout and co-
workers (2003) suggests that orexinergic perifornical neu-
rons send collateralized polysynaptic projections to the
motor cortex and to the central autonomic network.
Functional considerations
Previous studies (reviewed above) along with the data
presented in the current paper suggest the existence of
two distinct cell groups within LH—one located more
laterally at the medial edge of the cerebral peduncle and
one located more medially around the fornix. Although
both of these cell groups contain neurons that send de-
scending polysynaptic projections that collateralize to in-
nervate hindlimb muscle and adrenal gland, the perifor-
nical group is made up predominantly of orexinergic
neurons, whereas the peripeduncular group is made up
primarily of MCH-positive neurons.
Although we cannot directly evaluate the functional role
of this separation from the present study, previous ana-
tomical, physiological, and behavioral studies of LH offer
some clues on the possible functional roles of these two cell
groups. We have previously mapped the locations of
PSPMNs throughout the central nervous system (Kerman
et al., 2003, 2006a). Their pattern of distribution suggests
that one of their possible functions is to coordinate activ-
ities of the somatomotor and sympathetic systems in re-
sponse to stress. For example, a major cluster of such
neurons is found within the paraventricular nucleus of the
hypothalamus, which is the main neuroendocrine integra-
tor of the stress response (Swanson and Kuypers, 1980;
Herman and Cullinan, 1997; Reyes et al., 2003), as well as
within the periaqueductal gray, which mediates motor
and autonomic components of the “fight-or-flight” re-
sponse to stress (Bandler et al., 1991; Keay and Bandler,
2004).
In animals, stress responses can generally be classified
into either “active coping” or “passive coping” (Bandler et
al., 2000). Active coping responses are usually elicited by
escapable stressors such as the presence of a rival or a
predator, whereas inescapable or uncontrollable stressors,
such as deep muscular pain, elicit passive coping re-
sponses (Bandler et al., 2000). Active coping is character-
ized by increased somatomotor activity that is part of
escape or fighting behavior, as well as a hypertensive
response (Bandler et al., 2000). On the other hand, passive
coping is characterized by general quiescence and hypo-
tension (Bandler et al., 2000). Our data, taken together
with previous physiological and behavioral studies, sug-
gest that the perifornical orexinergic PSPMNs participate
in the expression of the active coping response to stress,
whereas the peripeduncular MCH-positive PSPMNs sup-
port the passive coping stress response.
The concept that orexin and MCH transmitter systems
are involved in mediating stress responses is supported by
findings that acute stressors induce Fos expression in
orexinergic neurons (Winsky-Sommerer et al., 2004),
whereas intracerebroventricular infusions of MCH in-
crease anxiety-like behavior in mice on the elevated plus
maze (Smith et al., 2006). Furthermore, chemical disinhi-
bition of the perifornical area leads to increased blood
pressure and heart rate, which are hallmarks of the fight-
or-flight response; this effect is attenuated in orexin
knockout mice (Kayaba et al., 2003). Likewise, awake
behaving orexin knockout mice exhibit decreased cardio-
vascular and behavioral responses to acute social stres-
sors (Kayaba et al., 2003). These data are in agreement
with the concept that activity of the perifornical orexiner-
gic PSPMNs participates in the expression of active coping
stress responses.
In contrast to orexins, MCH neurotransmission likely
plays a role in mediating quiescent or passive stress re-
sponses. Support for this notion comes from several lines
of investigation. For example, melanin-concentrating hor-
mone 1 receptor-deficient mice are hyperactive in their
home-cages across a 24-hour period, suggesting that in-
creased MCH transmission would lead to decreased levels
of activity (Marsh et al., 2002). Furthermore, chronic in-
tracerebroventricular administration of MCH leads to hy-
potension (Messina and Overton, 2007), a response that
would be expected as part of a reaction to chronic inescap-
able stress. MCH neurons also express -aminobutyric
acid (GABA)ergic characteristics, including synthetic en-
zymes for GABA synthesis and GABAergic receptors
(Harthoorn et al., 2005; Hervieu, 2006). Finally, chemical
stimulation with excitatory amino acid infusions within
the peripeduncular portion of LH leads to hypotensive
responses (Allen and Cechetto, 1992; Pajolla and de Agu-
iar Correa, 2004), whereas similar stimuli in the perifor-
nical region lead to hypertensive responses (Allen and
Cechetto, 1992). These stimulation sites correspond
closely to the locations of MCH-positive and orexinergic
PSPMNs identified in the present study.
CONCLUSIONS
In the current study we used a virally mediated trans-
synaptic tract-tracing approach to identify neurons with
putative dual somatomotor-sympathetic function. These
PSPMNs polysynaptically innervate adrenal gland and
hindlimb muscle and likely participate in the expression
of responses to stress. Our data indicate that these neu-
rons form two distinct clusters within LH, those that
synthesize orexins, which are located medially around the
fornix, and those that express MCH, which are located
laterally at the medial edge of cerebral peduncle. On the
basis of previous studies, we hypothesize that these two
groups of neurons are recruited differentially by different
stressors. Orexinergic perifornical PSPMNs likely partic-
ipate in active coping responses and may thus be recruited
by escapable stressors, whereas MCH-positive peripedun-
cular PSPMNs likely participate in passive coping re-
sponses and may thus be recruited by inescapable stres-
sors. Future investigations will be required to test this
hypothesis.
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